Similar Items: Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
- Estimated Cost of Adverse Event Management in Treatment Naïve Non-small Cell Lung Cancer Patients with Common EGFR Mutations Treated with Amivantamab Plus Lazertinib and Osimertinib Plus Chemotherapy
- Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia
- Detecting Spatiotemporal Patterns of Newly Diagnosed HIV Infection in the China-Myanmar Border Region, 2010 to 2022: Longitudinal Observational Study
- Italy’s National Healthcare System and eHealth Landscape
- Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
- De regressu: Intergenerational conflicts over legality and belonging in migrant family entrepreneurship in Italy